|
1
|
Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
|
Endoscopy
|
2006
|
1.24
|
|
2
|
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
|
J Hepatol
|
2000
|
1.21
|
|
3
|
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
|
HIV Med
|
2004
|
1.13
|
|
4
|
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
|
Aliment Pharmacol Ther
|
2007
|
0.95
|
|
5
|
Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
|
HIV Med
|
2013
|
0.92
|
|
6
|
Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease.
|
Am J Pathol
|
1995
|
0.91
|
|
7
|
Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.
|
World J Gastroenterol
|
2005
|
0.90
|
|
8
|
Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.
|
J Med Virol
|
2002
|
0.88
|
|
9
|
Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.
|
Drug Alcohol Depend
|
2011
|
0.87
|
|
10
|
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
|
J Viral Hepat
|
2011
|
0.85
|
|
11
|
Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.
|
Mod Pathol
|
2001
|
0.84
|
|
12
|
Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.
|
AIDS
|
2001
|
0.83
|
|
13
|
Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
|
J Viral Hepat
|
2009
|
0.79
|
|
14
|
Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.
|
Psychopharmacology (Berl)
|
1985
|
0.79
|
|
15
|
Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses.
|
Psychopharmacology (Berl)
|
1986
|
0.79
|
|
16
|
Occurrence of hepatocellular carcinoma in nonfibrotic livers.
|
Hepatology
|
2000
|
0.78
|
|
17
|
Variations in the expression of cell-adhesion molecules on liver-associated lymphocytes and peripheral-blood lymphocytes in patients with and without liver metastasis.
|
Int J Cancer
|
1995
|
0.77
|
|
18
|
Detection of cell-adhesion molecules on human liver-associated lymphocytes.
|
Immunology
|
1994
|
0.76
|
|
19
|
What hides behind an intention-to-treat analysis?
|
Hepatology
|
2001
|
0.75
|
|
20
|
Human liver passenger cells suppress autologous and allogeneic blood lymphocytes proliferation.
|
Transplant Proc
|
1997
|
0.75
|